Literature DB >> 8083230

Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2.

J D Sharp1, R T Pickard, X G Chiou, J V Manetta, S Kovacevic, J R Miller, A D Varshavsky, E F Roberts, B A Strifler, D N Brems.   

Abstract

The Ca(2+)-sensitive cytosolic phospholipase A2 (cPLA2) displays both a phospholipase A2 and a lysophospholipase activity. Numerous hydrolases, including lipases, catalyze the hydrolysis of ester bonds by means of an active site triad of amino acids that includes a serine or a cysteine residue. We have examined whether human cPLA2 belongs to this class of enzymes by using site-directed mutagenesis. Although chemical inactivation of cPLA2 by the sulfhydryl reagent N-ethylmaleimide made it appear that cysteine(s) may be essential for catalysis, all 9 cysteine residues of cPLA2 proved dispensable, allowing near-normal enzyme activity when substituted by alanine. We noted that cPLA2 contains a 110-amino-acid region with sequence homology to phospholipase B (PLB) from Penicillium notatum. Interestingly, one of the conserved serines of cPLA2, Ser-228, within this domain aligns with the lipase consensus sequence Gly-X(Leu)-Ser(137)-X(Gly)-Gly of PLB. Replacement of Ser-228 by alanine (or threonine or cysteine) yielded catalytically inactive cPLA2, even though the native conformation was maintained as determined by CD spectroscopy. Likewise, the lysophospholipase activity was completely abolished by the Ser-228 mutations. In contrast, substitution by alanine of three different serines of cPLA2 (Ser-195, Ser-215, or Ser-577) that also aligned with the PLB sequence allowed for substantial enzymatic activity of cPLA2. Our findings provide evidence that 1) Ser-228 participates in the catalytic mechanism of cPLA2 and that 2) both the phospholipase A2 and the lysophospholipase activities of cPLA2 are catalyzed by the same active site residue(s).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083230

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

2.  Molecular characterization and serodiagnosis analysis of a novel lysophospholipase from Clonorchis sinensis.

Authors:  Changling Ma; Xuchu Hu; Fengyu Hu; Yanwen Li; Xiaoxiang Chen; Zhenwen Zhou; Fangli Lu; Jin Xu; Zhongdao Wu; Xinbing Yu
Journal:  Parasitol Res       Date:  2007-02-23       Impact factor: 2.289

3.  Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.

Authors:  Chang Han; Kyu Lim; Lihong Xu; Guiying Li; Tong Wu
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

4.  Genetic evidence for a SPO1-dependent signaling pathway controlling meiotic progression in yeast.

Authors:  Gela G Tevzadze; Jessica V Pierce; Rochelle Easton Esposito
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

Review 5.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

6.  Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.

Authors:  Daren Stephens; Efrosini Barbayianni; Violetta Constantinou-Kokotou; Anna Peristeraki; David A Six; Jennifer Cooper; Richard Harkewicz; Raymond A Deems; Edward A Dennis; George Kokotos
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

7.  Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.

Authors:  Varnavas D Mouchlis; Vasiliki Michopoulou; Violetta Constantinou-Kokotou; Thomas Mavromoustakos; Edward A Dennis; George Kokotos
Journal:  J Chem Inf Model       Date:  2012-01-10       Impact factor: 4.956

8.  Cysteine-less glycosylphosphatidylinositol-specific phospholipase C is inhibited competitively by a thiol reagent: evidence for glyco-mimicry by p-chloromercuriphenylsulphonate.

Authors:  Julie D Stanton; Mohammad B Rashid; Kojo Mensa-Wilmot
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

9.  Group IVC cytosolic phospholipase A2gamma is farnesylated and palmitoylated in mammalian cells.

Authors:  Dawn E Tucker; Allison Stewart; Laxman Nallan; Pravine Bendale; Farideh Ghomashchi; Michael H Gelb; Christina C Leslie
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

10.  Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase.

Authors:  Jennifer A Mietla; Dayanjan S Wijesinghe; L Alexis Hoeferlin; Michael D Shultz; Ramesh Natarajan; Alpha A Fowler; Charles E Chalfant
Journal:  J Lipid Res       Date:  2013-04-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.